Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer.
Amatangelo MD, Goodyear S, Varma D, Stearns ME. Amatangelo MD, et al. Among authors: stearns me. Carcinogenesis. 2012 Oct;33(10):1965-75. doi: 10.1093/carcin/bgs227. Epub 2012 Jul 12. Carcinogenesis. 2012. PMID: 22791812 Free PMC article.
Retraction: Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M, Hu Y, Amantagelo MD, Stearns ME. Wang M, et al. Among authors: stearns me. Mol Cancer Res. 2012 Apr;10(4):570. doi: 10.1158/1541-7786.MCR-12-0085. Epub 2012 Mar 20. Mol Cancer Res. 2012. PMID: 22434856 Free article. No abstract available.
Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors.
Stearns ME, Wang M. Stearns ME, et al. Transl Oncol. 2011 Jun;4(3):147-56. doi: 10.1593/tlo.10286. Epub 2011 Jun 1. Transl Oncol. 2011. PMID: 21633670 Free PMC article.
Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M, Hu Y, Amatangelo MD, Stearns ME. Wang M, et al. Among authors: stearns me. Mol Cancer Res. 2011 Jan;9(1):36-50. doi: 10.1158/1541-7786.MCR-10-0158. Epub 2010 Dec 8. Mol Cancer Res. 2011. PMID: 21148031 Free article. Retracted.
Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.
Stearns ME, Amatangelo MD, Varma D, Sell C, Goodyear SM. Stearns ME, et al. Am J Pathol. 2010 Dec;177(6):3169-79. doi: 10.2353/ajpath.2010.100330. Epub 2010 Oct 22. Am J Pathol. 2010. PMID: 20971741 Free PMC article.
Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.
Goodyear SM, Kheyfets SB, Garcia FU, Stearns ME. Goodyear SM, et al. Among authors: stearns me. Prostate. 2009 Jun 15;69(9):982-90. doi: 10.1002/pros.20945. Prostate. 2009. PMID: 19301310
Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
Goodyear SM, Amatangelo MD, Stearns ME. Goodyear SM, et al. Among authors: stearns me. Prostate. 2009 May 15;69(7):689-98. doi: 10.1002/pros.20918. Prostate. 2009. PMID: 19143028 Free PMC article.
RPS2: a novel therapeutic target in prostate cancer.
Wang M, Hu Y, Stearns ME. Wang M, et al. Among authors: stearns me. J Exp Clin Cancer Res. 2009 Jan 12;28(1):6. doi: 10.1186/1756-9966-28-6. J Exp Clin Cancer Res. 2009. PMID: 19138403 Free PMC article.
The ABCA5 protein: a urine diagnostic marker for prostatic intraepithelial neoplasia.
Hu Y, Wang M, Veverka K, Garcia FU, Stearns ME. Hu Y, et al. Among authors: stearns me. Clin Cancer Res. 2007 Feb 1;13(3):929-38. doi: 10.1158/1078-0432.CCR-06-1718. Clin Cancer Res. 2007. PMID: 17289887 Free article.
Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.
Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Meucci O, Fatatis A. Dolloff NG, et al. Among authors: stearns me. Oncogene. 2005 Oct 13;24(45):6848-54. doi: 10.1038/sj.onc.1208815. Oncogene. 2005. PMID: 16007172 Free PMC article.
84 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback